National Health Investors (NYSE:NHI) Updates FY 2024 Earnings Guidance

National Health Investors (NYSE:NHI - Get Free Report) issued an update on its FY 2024 earnings guidance on Monday morning. The company provided earnings per share guidance of 4.370-4.430 for the period, compared to the consensus earnings per share estimate of 4.350. The company issued revenue guidance of -.

National Health Investors Trading Down 0.7 %

NHI traded down $0.47 on Monday, hitting $64.25. The company had a trading volume of 137,213 shares, compared to its average volume of 169,745. National Health Investors has a 12-month low of $48.51 and a 12-month high of $65.23. The business's fifty day simple moving average is $60.55 and its 200 day simple moving average is $56.25. The company has a market cap of $2.79 billion, a PE ratio of 20.53 and a beta of 0.95. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.90.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 3rd. Shareholders of record on Thursday, March 28th were paid a $0.90 dividend. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $3.60 dividend on an annualized basis and a yield of 5.60%. National Health Investors's payout ratio is 115.02%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on NHI shares. Truist Financial upped their price target on shares of National Health Investors from $55.00 to $58.00 and gave the stock a hold rating in a report on Thursday, April 4th. Wells Fargo & Company raised shares of National Health Investors from an equal weight rating to an overweight rating and lifted their price target for the company from $55.00 to $63.00 in a research note on Monday, February 26th. Wedbush increased their price objective on National Health Investors from $64.00 to $66.00 and gave the stock an outperform rating in a research note on Monday, March 18th. StockNews.com downgraded National Health Investors from a buy rating to a hold rating in a report on Thursday, April 18th. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on National Health Investors in a report on Tuesday, January 30th. They issued a buy rating and a $69.00 target price for the company. Five investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of Hold and an average target price of $60.50.

Insider Activity at National Health Investors

In related news, Director Charlotte A. Swafford acquired 10,000 shares of the company's stock in a transaction that occurred on Tuesday, February 27th. The shares were bought at an average price of $58.69 per share, with a total value of $586,900.00. Following the completion of the transaction, the director now directly owns 110,185 shares in the company, valued at $6,466,757.65. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 8.21% of the stock is owned by corporate insiders.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.